Senate bill would protect FDA user fees from sequester cuts

08/2/2013 | (Boston)

A bipartisan bill that would shield FDA user fees for drugs and medical devices from sequestration has been introduced in the Senate, following a similar measure recently introduced in the House. AdvaMed President and CEO Stephen Ubl called the Senate move "a win-win-win for FDA, the industry and the millions of American patients who will benefit from more timely access to innovative medical technologies."

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA